Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

68Ga-PSMA PET/CT for Detection of Recurrent Prostate Cancer After Initial Therapy

NCT02940262 is registered in ClinicalTrials.gov with Jonsson Comprehensive Cancer Center as lead sponsor.

NCT NCT02940262
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02940262 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
68Ga-PSMA PET/CT for Detection of Recurrent Prostate Cancer After Initial Therapy
Lead sponsor
Jonsson Comprehensive Cancer Center
Phase
Phase 3
Overall status
Completed
Start date
September 15, 2016
Completion date
June 18, 2021
Enrollment
1,138 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate adenocarcinoma, recurrent prostate carcinoma